Atticus Wealth Management »

Abcellera Biologics shares owned by Atticus Wealth Management

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Atticus Wealth Management from 13F filings

Historical chart of Atticus Wealth Management investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Atticus Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Atticus Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $453 100 4.53

More positions owned by Atticus Wealth Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Neos Etf Trust Neos Enh Inc 1-3 (CSHI)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Ishares Tr Short Treas Bd (SHV)
Ishares Tr S&p 100 Etf (OEF)
Apple (AAPL)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation (MSFT)
Coca-Cola Company (KO)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Technology (XLK)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)

View all positions for Atticus Wealth Management

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Baillie Gifford & Co
Ing Investment Management
Credit Suisse
OrbiMed Advisors
Arrowpoint Asset Management
BlackRock
Founders Fund VII Management
Lazard Asset Management
Federated Investors
Casdin Capital
Prosight Management
Guardian Capital Advisors
Two Sigma Advisers
Two Sigma Investments

View all funds holding Abcellera Biologics